OptimizeRxOPRX
Market Cap: $138M
About: OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its products offering are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
Employees: 136
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
222% more call options, than puts
Call options by funds: $1.76M | Put options by funds: $548K
52% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 25
0.83% more ownership
Funds ownership: 70.77% [Q1] → 71.6% (+0.83%) [Q2]
4% less funds holding
Funds holding: 96 [Q1] → 92 (-4) [Q2]
16% less capital invested
Capital invested by funds: $156M [Q1] → $131M (-$25.3M) [Q2]
18% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 22
50% less funds holding in top 10
Funds holding in top 10: 2 [Q1] → 1 (-1) [Q2]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
RBC Capital Sean Dodge 55% 1-year accuracy 24 / 44 met price target | 86%upside $14 | Outperform Maintained | 16 Aug 2024 |
Barclays Stephanie Davis 89% 1-year accuracy 8 / 9 met price target | 46%upside $11 | Equal-Weight Maintained | 12 Aug 2024 |
JMP Securities Constantine Davides 32% 1-year accuracy 7 / 22 met price target | 112%upside $16 | Market Outperform Reiterated | 24 Jun 2024 |
JMP Securities Constantine Davides 32% 1-year accuracy 7 / 22 met price target | 112%upside $16 | Market Outperform Reiterated | 21 Jun 2024 |